[EN] HETEROCYCLIC COMPOUNDS AS CLASS II PHOSPHOINOSITIDE 3-KINASE INHIBITORS [FR] COMPOSÉS HÉTÉROCYCLIQUES EN TANT QU'INHIBITEURS DE PHOSPHOINOSITIDE 3-KINASE DE CLASSE II
Synthesis of Thiazole and Fused Thiazolo Derivatives
作者:Uro? Urleb、Richard Neidlein、Walter Kramer
DOI:10.1002/hlca.19930760127
日期:1993.2.10
of thiazole and fusedthiazoloderivatives 2–4, 6–8, 10a–11b, 13–16 from heterocylic isothiocyanates 1, 5, 9, and 12 bearing an ortho ester group and bifunctional reagents, such as substituted propargylamines, is described. Different regioselectivity of intramolecular nucleophilic attack of the thiourea S-atom on the C C bond, resulting in the formation of both thiazolo and thiazino derivatives, as
The reactions of heterocyclic isothiocyanates bearing an<i>ortho</i>ester group with aminoalcohols
作者:Uroš Urleb
DOI:10.1002/jhet.5570350331
日期:1998.5
bearing an o-ester group were converted to thiourea derivatives 2a-c, 6a-b, and 10a-b, respectively, using β-aminoalcohols, and to the fused ringsystems, e.g., thieno[3,2-d]pyrimidine 4a-b, pyrido[2,3-d]pyrimidine 8, pteridine 11a, thiazolo[3,2-a]pyrido[2,3-d]pyrimidine 7a-b, and thiazolo[3,2-a]mieno[3,2-d]pyrirnidine 3a-c, derivatives.
杂环异硫氰酸酯1,5,9,轴承的直径: -酯基团转化为硫脲衍生物2A-C,图6a-b ,和图10A-B ,分别使用β氨基醇,以及稠环体系,例如,噻吩并[3,2-d]嘧啶4a-b,吡啶并[2,3- d ]嘧啶8,蝶啶11a,噻唑并[3,2- a ]吡啶并[2,3 - d ]嘧啶7a-b和噻唑并[ 3,2- a ] mieno [3,2 - d ]吡啶3a-c衍生物。
URLEB, UROS;NEIDLEIN, RICHARD;KRAMER, WALTER, J. HETEROCYCL. CHEM., 27,(1990) N, C. 433-437
作者:URLEB, UROS、NEIDLEIN, RICHARD、KRAMER, WALTER
DOI:——
日期:——
Structural Basis for Highly Selective Class II Alpha Phosphoinositide-3-Kinase Inhibition
作者:Murat Kücükdisli、Hassen Bel-Abed、Davide Cirillo、Wen-Ting Lo、Nina-Louisa Efrém、André Horatscheck、Liudmila Perepelittchenko、Polina Prokofeva、Theresa A. L. Ehret、Silke Radetzki、Martin Neuenschwander、Edgar Specker、Guillaume Médard、Susanne Müller、Stephanie Wilhelm、Bernhard Kuster、Jens Peter von Kries、Volker Haucke、Marc Nazaré
DOI:10.1021/acs.jmedchem.3c01319
日期:2023.10.26
HETEROCYCLIC COMPOUNDS AS CLASS II PHOSPHOINOSITIDE 3-KINASE INHIBITORS